Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma

International Journal of Molecular Medicine

Volumn 29, Issue 4, 2012, Pages 704-710

  Li, Ying ^a   Yang, Ze Song ^a   Song, Jun Jun ^a   Liu, Qiong ^a   Chen, Jian Bin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Methylation; Myeloma; Protocadherin 10

Indexed keywords

PROTOCADHERIN 10; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHORIOALLANTOIS; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; EMBRYO; EPIGENETICS; FEMALE; GENE ACTIVATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR CELL; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ADULT; AGED; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC;

EID: 84863237209     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.880     Document Type: Article

References (32)

1. Wolverton T and Lalande M: Identification and characterization of three members of a novel subclass of protocadherins. Genomics 76: 66-72, 2001. (Pubitemid 32744625)
2. Kim SY, Yasuda S, Tanaka H, Yamagata K and Kim H: Non-clustered protocadherin. Cell Adh Migr 5: 97-105, 2011.
3. Ying J, Li H, Seng TJ, et al: Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080, 2006. (Pubitemid 43277014)
4. Li Z, Xie J, Li W, et al: Identification and characterization of human PCDH10 gene promoter. Gene 475: 49-56, 2011.
5. Bertrand KC, Mack SC, Northcott PA, et al: PCDH10 is a candidate tumour suppressor gene in medulloblastoma. Childs Nerv Syst 27: 1243-1249, 2011.
6. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002. (Pubitemid 34587077)
7. Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet 21: 163-167, 1999. (Pubitemid 29070360)
8. Baylin SB and Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16: 168-174, 2000. (Pubitemid 30169152)
9. Giuliani N, Storti P, Bolzoni M, Palma BD and Bonomini S: Angiogenesis and multiple myeloma. Cancer Microenviron: July 7, 2011 (Epub ahead of print).
10. Anderson KC and Carrasco RD: Pathogenesis of myeloma. Annu Rev Pathol 6: 249-274, 2011.
11. Asosingh K, De Raeve H, Menu E, et al: Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity. Blood 103: 3131-3137, 2004. (Pubitemid 38451691)
12. Kim JS, Yu HK, Ahn JH, et al: Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem Biophys Res Commun 313: 534-540, 2004.
13. Crivellato E, Nico B, Vacca A, Djonov V, Presta M and Ribatti D: Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia 18: 331-336, 2004. (Pubitemid 38240050)
14. Esteller M, Risques RA, Toyota M, et al: Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 61: 4689-4692, 2001. (Pubitemid 32691877)
15. Cravo M, Fidalgo P, Pereira AD, et al: DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 3: 473-479, 1994. (Pubitemid 24360815)
16. Laird PW and Jaenisch R: DNA methylation and cancer. Hum Mol Genet 3 Spec No: 1487-1495, 1994. (Pubitemid 24295497)
17. Kuo HK, Griffith JD and Kreuzer KN: 5-Azacytidine induced methyltransferase-DNA adducts block DNA replication in vivo. Cancer Res 67: 8248-8254, 2007. (Pubitemid 47395162)
18. Sonoda I, Imoto I, Inoue J, et al: Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64: 3741-3747, 2004. (Pubitemid 38697280)
19. Imoto I, Yuki Y, Sonoda I, et al: Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res 63: 5691-5696, 2003. (Pubitemid 37187462)
20. Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070, 2001. (Pubitemid 32758075)
21. Walker BA, Wardell CP, Chiecchio L, et al: Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood 117: 553-562, 2011.
22. Martinez-Garcia E, Popovic R, Min DJ, et al: The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 117: 211-220, 2011.
23. Singh AV, Bandi M, Raje N, et al: A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells. Blood 117: 5692-5700, 2011.
24. Vacca A and Ribatti D: Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells. Recent Results Cancer Res 183: 87-95, 2011.
25. Zhang Y and Daaka Y: PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. Blood 118: 5355-5364, 2011.
26. Potente M, Gerhardt H and Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell 146: 873-887, 2011.
27. Carmona FJ and Esteller M: IDIBELL Cancer conference on metastasis and angiogenesis. Cancer Res 71: 6097-6101, 2011.
28. Cohen KS: Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant? Leuk Lymphoma 52: 1173-1175, 2011.
29. Oki Y, Jelinek J, Shen L, Kantarjian HM and Issa JP: Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood 111: 2382-2384, 2008. (Pubitemid 351451448)
30. Balassiano K, Lima S, Jenab M, et al: Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett 311: 85-95, 2011.
31. Stewart DJ, Issa JP, Kurzrock R, et al: Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas. Clin Cancer Res 15: 3881-3888, 2009.
32. Fabiani E, Leone G, Giachelia M, et al: Analysis of genome-wide methylation and gene expression induced by 5-aza-2′-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leuk Lymphoma 51: 2275-2284, 2010.